Turn Therapeutics Inc.
PublicTurn Therapeutics Inc. is now publicly traded
The data on this page reflects Turn Therapeutics Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Early Funding
Aug 14, 2026
Total Funding Raised
$26.65M
Company Overview
Turn Therapeutics Inc. operates in Healthcare and is based in the United States. It has raised $26.65M.
Turn Therapeutics Inc. is a clinical-stage biotechnology company that develops targeted, non-systemic therapies for inflammatory skin diseases, infectious diseases, and advanced wound care.
Sector
Healthcare
AI Layer
Non-AI
Turn Therapeutics Inc. Comparables
Compare Turn Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hallux Inc | 64% | |
| Seanergy Dermatology Ltd. | 50% | |
| AMR Bio Limited | 44% |
For institutional investors. Book with your work email.
Turn Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 14, 2026 | ||||
| Debt | Mar 24, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Turn Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avenue Capital Group | Debt |
Turn Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.